Abeona Therapeutics Inc banner

Abeona Therapeutics Inc
NASDAQ:ABEO

Watchlist Manager
Abeona Therapeutics Inc Logo
Abeona Therapeutics Inc
NASDAQ:ABEO
Watchlist
Price: 4.42 USD -0.67% Market Closed
Market Cap: $239.5m

Wall Street
Price Targets

ABEO Price Targets Summary
Abeona Therapeutics Inc

Wall Street analysts forecast ABEO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABEO is 21.06 USD with a low forecast of 14.14 USD and a high forecast of 29.4 USD.

Lowest
Price Target
14.14 USD
220% Upside
Average
Price Target
21.06 USD
376% Upside
Highest
Price Target
29.4 USD
565% Upside
Abeona Therapeutics Inc Competitors:
Price Targets
VINP
Vinci Partners Investments Ltd
38% Upside
MRVL
Marvell Technology Group Ltd
30% Upside
ESQ
Esquire Financial Holdings Inc
14% Upside
STG
Strip Tinning Holdings PLC
168% Upside
TCPC
BlackRock TCP Capital Corp
79% Upside

Revenue
Forecast

9% / Year
Past Growth
245% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
9% / Year
Past Growth
245% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

For the last 14 years the compound annual growth rate for Abeona Therapeutics Inc's revenue is 9%. The projected CAGR for the next 3 years is 245%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-94%
Average Miss
N/A
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-94%
Average Miss

The compound annual growth rate of Abeona Therapeutics Inc's net income for the next 3 years is 29%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ABEO's stock price target?
Price Target
21.06 USD

According to Wall Street analysts, the average 1-year price target for ABEO is 21.06 USD with a low forecast of 14.14 USD and a high forecast of 29.4 USD.

What is Abeona Therapeutics Inc's Revenue forecast?
Projected CAGR
245%

For the last 14 years the compound annual growth rate for Abeona Therapeutics Inc's revenue is 9%. The projected CAGR for the next 3 years is 245%.

What is Abeona Therapeutics Inc's Net Income forecast?
Projected CAGR
29%

The compound annual growth rate of Abeona Therapeutics Inc's net income for the next 3 years is 29%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett